Addressing the diagnostic odyssey beyond variant calling: a perspective on long-read sequencing and context-aware genome interpretation

Short-read exome and genome sequencing have transformed not only clinical genetics but also many other medical specialties that rely on genomic information. Yet, in clinical genetics, many individuals remain undiagnosed because the relevant disease mechanism cannot always be represented as an isolated variant at a single genomic coordinate. Phase, structural configuration, repeat composition, paralog assignment, methylation, and transcript consequences can each influence whether a variant is pathogenic. Long-read sequencing preserves molecular continuity across kilobases of native DNA and, in separate, complementary assays, across full-length RNA transcripts. Its clinical value includes both detecting previously missed variation and reconstructing the molecular configuration of detected findings. In this Perspective, we argue that clinical genomics should increasingly treat haplotypes, structural alleles, repeat alleles, and allele-specific regulatory states as primary diagnostic objects. Using a composite unresolved recessive-disease scenario, we place this perspective within the diagnostic odyssey, discuss health economics and outcomes research (HEOR) considerations, propose a context-aware workflow, and define priorities for validation and evidence generation. We identify potential value under reanalysis as a hypothesis requiring economic evaluation and argue that most current clinical databases are not designed to adequately represent the configurations these assays produce. Long-read sequencing need not universally replace short-read testing; its most compelling role is in settings where preserving molecular continuity changes the clinical meaning and downstream value of the result.

Authors

Institutions

Publication Details

Journal
Frontiers in Genetics
Published
2026-11-13
DOI
https://doi.org/10.3389/fgene.2026.1965842
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Addressing the diagnostic odyssey beyond variant calling: a perspective on long-read sequencing and context-aware genome interpretation

Rong Mao, Shashirekha Shetty, Rajdeep Das, Kristin K. Deeb et al.
2 links
Frontiers in Genetics
Genomics and Rare Diseases
article

Addressing the diagnostic odyssey beyond variant calling: a perspective on long-read sequencing and context-aware genome interpretation

Rong Mao, Shashirekha Shetty, Rajdeep Das, Kristin K. Deeb, Honey V. Reddi, John Pina
article en

Abstract

Short-read exome and genome sequencing have transformed not only clinical genetics but also many other medical specialties that rely on genomic information. Yet, in clinical genetics, many individuals remain undiagnosed because the relevant disease mechanism cannot always be represented as an isolated variant at a single genomic coordinate. Phase, structural configuration, repeat composition, paralog assignment, methylation, and transcript consequences can each influence whether a variant is pathogenic. Long-read sequencing preserves molecular continuity across kilobases of native DNA and, in separate, complementary assays, across full-length RNA transcripts. Its clinical value includes both detecting previously missed variation and reconstructing the molecular configuration of detected findings. In this Perspective, we argue that clinical genomics should increasingly treat haplotypes, structural alleles, repeat alleles, and allele-specific regulatory states as primary diagnostic objects. Using a composite unresolved recessive-disease scenario, we place this perspective within the diagnostic odyssey, discuss health economics and outcomes research (HEOR) considerations, propose a context-aware workflow, and define priorities for validation and evidence generation. We identify potential value under reanalysis as a hypothesis requiring economic evaluation and argue that most current clinical databases are not designed to adequately represent the configurations these assays produce. Long-read sequencing need not universally replace short-read testing; its most compelling role is in settings where preserving molecular continuity changes the clinical meaning and downstream value of the result.

Frontiers in GeneticsVol. 17
Emory Healthcare (US), Emory University (US), University of Utah (US), University Hospitals of Cleveland (US), University Hospitals Cleveland Medical Center (US), ARUP Institute for Clinical and Experimental Pathology (US), Case Western Reserve University (US), ARUP Laboratories (United States) (US)
Good health and well-being
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon